Precigen to participate in guggenheim healthcare talks oncology day

Germantown, md., feb. 4, 2021 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced helen sabzevari, phd, president and ceo of precigen, will...
PGEN Ratings Summary
PGEN Quant Ranking